{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:10:28Z","timestamp":1789150228040,"version":"build-2803163510"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["173383"],"award-info":[{"award-number":["173383"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","award":["1138-05"],"award-info":[{"award-number":["1138-05"]}],"id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>In recent years, immunotherapy of patients with higher-risk non-muscle invasive bladder cancer (NMIBC) in North America has relied on the use of the TICE strain of BCG. However, limitations in the supply chain have warranted investigation of the therapeutic benefit of other strains of BCG, such as BCG-Russia. Trained immunity, a form of innate immune memory, is now widely believed to be an important component of the therapeutic benefit of BCG. Therefore, in the present study we compared the effects of BCG-TICE and BCG-Russia on the acquisition of trained immunity and related secondary immune responses. C57BL\/6 mice received a single intravenous injection of BCG-Russia or BCG-TICE. Four weeks later, bone marrow was collected for flow cytometric analysis of hematopoietic stem and progenitor cell (HSPC) populations, generation of bone marrow-derived macrophages, functional assessment of trained immunity, and transcriptomic profiling. Compared with BCG-Russia, BCG-TICE elicited increased levels of trained immunity, characterized by higher production of several proinflammatory cytokines upon secondary activation. BCG promoted the expansion of HSPCs independent of strain. BCG-TICE was linked to upregulation of key inflammation-related genes and enrichment of functionally relevant pathways. The results of this study reveal strain-dependent differences in the ability of BCG to induce innate immune memory and inflammatory pathways that could ultimately determine efficacy of immunotherapy of patients with NMIBC.<\/jats:p>","DOI":"10.1371\/journal.pone.0357950","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:44:13Z","timestamp":1789148653000},"page":"e0357950","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential effects of BCG-Russia and BCG-TICE on trained immunity: Potential implications for bladder cancer immunotherapy"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1792-1180","authenticated-orcid":true,"given":"Richard W.","family":"Nauman","sequence":"first","affiliation":[{"name":"Queen\u2019s University","place":["Kingston, Ontario, Canada"],"department":["Department of Biomedical and Molecular Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Greer","sequence":"additional","affiliation":[{"name":"Queen\u2019s University","place":["Kingston, Ontario, Canada"],"department":["Department of Pathology and Molecular Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Craig","sequence":"additional","affiliation":[{"name":"Queen\u2019s University","place":["Kingston, Ontario, Canada"],"department":["Department of Biomedical and Molecular Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Cotechini","sequence":"additional","affiliation":[{"name":"Queen\u2019s University","place":["Kingston, Ontario, Canada"],"department":["Department of Biomedical and Molecular Sciences"]},{"name":"Queen\u2019s University","place":["Kingston, Ontario, Canada"],"department":["Department of Urology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Robert","family":"Siemens","sequence":"additional","affiliation":[{"name":"Queen\u2019s University","place":["Kingston, Ontario, Canada"],"department":["Department of Urology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7014-8639","authenticated-orcid":true,"given":"Charles H.","family":"Graham","sequence":"additional","affiliation":[{"name":"Queen\u2019s University","place":["Kingston, Ontario, Canada"],"department":["Department of Biomedical and Molecular Sciences"]},{"name":"Queen\u2019s University","place":["Kingston, Ontario, Canada"],"department":["Department of Urology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"pone.0357950.ref001","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-319-64371-7_8","article-title":"Evolution and strain variation in BCG","volume":"1019","author":"AM Abdallah","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"pone.0357950.ref002","article-title":"Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Full-text","volume":"15","author":"B Bhindi","year":"2021","journal-title":"Can Urol Assoc J"},{"issue":"10","key":"pone.0357950.ref003","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1007\/s00432-021-03571-0","article-title":"Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate\/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis","volume":"147","author":"F Del Giudice","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"pone.0357950.ref004","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.juro.2013.01.084","article-title":"A prospective comparative study of intravesical bacillus Calmette-Gu\u00e9rin therapy with the Tokyo or Connaught strain for nonmuscle invasive bladder cancer","volume":"190","author":"A Sengiku","year":"2013","journal-title":"J Urol"},{"key":"pone.0357950.ref005","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-5347(01)67606-7","article-title":"A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder","volume":"153","author":"PD Vegt","year":"1995","journal-title":"J Urol"},{"issue":"11","key":"pone.0357950.ref006","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2016.05.033","article-title":"The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer","volume":"34","author":"JA Witjes","year":"2016","journal-title":"Urol Oncol"},{"issue":"7","key":"pone.0357950.ref007","doi-asserted-by":"crossref","DOI":"10.5489\/cuaj.8552","article-title":"Efficacy and tolerability of bacillus Calmette-Gu\u00e9rin strain Russia for the treatment of non-muscle-invasive bladder cancer analysis of a prospective registry","volume":"18","author":"S Flury-Sutter","year":"2024","journal-title":"Can Urol Assoc J"},{"issue":"4","key":"pone.0357950.ref008","article-title":"Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer","volume":"2000","author":"MD Shelley","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"pone.0357950.ref009","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.eururo.2006.01.017","article-title":"Management of BCG failures in superficial bladder cancer: a review","volume":"49","author":"JA Witjes","year":"2006","journal-title":"Eur Urol"},{"issue":"1","key":"pone.0357950.ref010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance Bacillus Calmette-Gu\u00e9rin","volume":"69","author":"S Cambier","year":"2016","journal-title":"Eur Urol"},{"issue":"6","key":"pone.0357950.ref011","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"MG Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"pone.0357950.ref012","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41585-020-0346-4","article-title":"Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer","volume":"17","author":"JH van Puffelen","year":"2020","journal-title":"Nat Rev Urol"},{"issue":"8","key":"pone.0357950.ref013","doi-asserted-by":"crossref","DOI":"10.5489\/cuaj.7066","article-title":"Innate immune memory is associated with increased disease-free survival in bladder cancer patients treated with bacillus Calmette-Gu\u00e9rin","volume":"15","author":"CH Graham","year":"2021","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"pone.0357950.ref014","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/BLC-230028","article-title":"Association of Histone H3 trimethylation in circulating monocytes with lack of early recurrence in patients with bladder cancer following BCG induction therapy","volume":"9","author":"J-F Par\u00e9","year":"2023","journal-title":"Bladder Cancer"},{"key":"pone.0357950.ref015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"E Kaufmann","year":"2018","journal-title":"Cell"},{"issue":"2","key":"pone.0357950.ref016","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ijc.34897","article-title":"Systemic versus localized Bacillus Calmette Gu\u00e9rin immunotherapy of bladder cancer promotes an anti-tumoral microenvironment: Novel role of trained immunity","volume":"155","author":"A Atallah","year":"2024","journal-title":"Int J Cancer"},{"issue":"14","key":"pone.0357950.ref017","article-title":"Multi-omics analysis reveals that linoleic acid metabolism is associated with variations of trained immunity induced by distinct BCG strains","volume":"10","author":"J-C Xu","year":"2024","journal-title":"Sci Adv"},{"issue":"8","key":"pone.0357950.ref018","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ccell.2025.05.002","article-title":"Microbial cancer immunotherapy reprograms hematopoiesis to enhance myeloid-driven anti-tumor immunity","volume":"43","author":"AW Daman","year":"2025","journal-title":"Cancer Cell"},{"issue":"2","key":"pone.0357950.ref019","doi-asserted-by":"crossref","first-page":"112141","DOI":"10.1016\/j.celrep.2023.112141","article-title":"Sterile liver injury induces a protective tissue-resident cDC1-ILC1 circuit through cDC1-intrinsic cGAS-STING-dependent IL-12 production","volume":"42","author":"AD Hildreth","year":"2023","journal-title":"Cell Rep"},{"issue":"8","key":"pone.0357950.ref020","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.4049\/jimmunol.178.8.5192","article-title":"Disparity in IL-12 release in dendritic cells and macrophages in response to Mycobacterium tuberculosis is due to use of distinct TLRs","volume":"178","author":"L Pompei","year":"2007","journal-title":"J Immunol"},{"key":"pone.0357950.ref021","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.imbio.2007.09.004","article-title":"Production of IL-12, IL-23 and IL-27p28 by bone marrow-derived conventional dendritic cells rather than macrophages after LPS\/TLR4-dependent induction by Salmonella Enteritidis","volume":"212","author":"S Siegemund","year":"2007","journal-title":"Immunobiology"},{"key":"pone.0357950.ref022","doi-asserted-by":"crossref","first-page":"1362289","DOI":"10.3389\/fimmu.2024.1362289","article-title":"The cholera toxin B subunit induces trained immunity in dendritic cells and promotes CD8 T cell antitumor immunity","volume":"15","author":"A Tepale-Segura","year":"2024","journal-title":"Front Immunol"},{"issue":"3","key":"pone.0357950.ref023","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","article-title":"T-cell subsets required for intravesical BCG immunotherapy for bladder cancer","volume":"150","author":"TL Ratliff","year":"1993","journal-title":"J Urol"},{"issue":"137","key":"pone.0357950.ref024","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003586","article-title":"Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer","volume":"4","author":"C Biot","year":"2012","journal-title":"Sci Transl Med"},{"issue":"6","key":"pone.0357950.ref025","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.1464-410X.2001.02394.x","article-title":"Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Gu\u00e9rin treatment","volume":"88","author":"F Saint","year":"2001","journal-title":"BJU Int"},{"issue":"4","key":"pone.0357950.ref026","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00262-016-1945-z","article-title":"Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer","volume":"66","author":"R Pichler","year":"2017","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"pone.0357950.ref027","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2249.2006.03191.x","article-title":"Role of Th1-stimulating cytokines in bacillus Calmette-Gu\u00e9rin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells","volume":"146","author":"Y Luo","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"pone.0357950.ref028","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3389\/fimmu.2018.01650","article-title":"TLR-3 stimulation skews M2 macrophages to M1 through IFN-\u03b1\u03b2 signaling and restricts tumor progression","volume":"9","author":"A Vidyarthi","year":"2018","journal-title":"Front Immunol"},{"key":"pone.0357950.ref029","doi-asserted-by":"crossref","first-page":"1026954","DOI":"10.3389\/fimmu.2022.1026954","article-title":"Major pathways involved in macrophage polarization in cancer","volume":"13","author":"C Kerneur","year":"2022","journal-title":"Front Immunol"},{"key":"pone.0357950.ref030","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3389\/fimmu.2017.01866","article-title":"Beta(2) integrins as regulators of dendritic cell, monocyte, and macrophage function","volume":"8","author":"L Schittenhelm","year":"2017","journal-title":"Front Immunol"},{"issue":"18","key":"pone.0357950.ref031","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.3390\/cancers13184712","article-title":"Tumor-associated macrophages in bladder cancer: biological role, impact on therapeutic response and perspectives for immunotherapy","volume":"13","author":"MM Leblond","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"8","key":"pone.0357950.ref032","article-title":"Macrophages directly kill bladder cancer cells through TNF signaling as an early response to BCG therapy","volume":"17","author":"MF Mart\u00ednez-L\u00f3pez","year":"2024","journal-title":"Dis Model Mech"},{"issue":"1","key":"pone.0357950.ref033","first-page":"362","article-title":"Immunotherapy of Bacillus Calmette\u2011Gu\u00e9rin by targeting macrophages against bladder cancer in a NOD\/scid IL2Rg\u2011\/\u2011 mouse model","volume":"22","author":"Q-L Tan","year":"2020","journal-title":"Mol Med Rep"},{"key":"pone.0357950.ref034","doi-asserted-by":"crossref","first-page":"15443","DOI":"10.1038\/srep15443","article-title":"Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations","volume":"5","author":"AM Abdallah","year":"2015","journal-title":"Sci Rep"},{"issue":"12","key":"pone.0357950.ref035","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1021\/acs.molpharmaceut.8b00919","article-title":"Application of BCG-CWS as a systemic adjuvant by using nanoparticulation technology","volume":"15","author":"H Masuda","year":"2018","journal-title":"Mol Pharm"},{"issue":"8","key":"pone.0357950.ref036","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.immuni.2025.05.026","article-title":"A fungal-derived adjuvant amplifies the antitumoral potency of Bacillus Calmette-Gu\u00e9rin via reprogramming granulopoiesis","volume":"58","author":"LF Jurado","year":"2025","journal-title":"Immunity"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:44:19Z","timestamp":1789148659000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357950"}},"subtitle":[],"editor":[{"given":"Odir Antonio","family":"Dellagostin","sequence":"first","affiliation":[{"name":"UFPL","place":["BRAZIL"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0357950","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}